The PSG report said high discontinuation rates are now playing a major role in coverage decisions, as nearly two-thirds of patients without type 2 diabetes who take GLP-1s discontinue treatment within one year. In addition, 72% of those surveyed indicated that discontinuation rates and weight regain were at least moderately influential in their GLP-1 coverage decisions. Discontinuation rates are very high and employers want to know if this will actually provide a return on their investment if they (workers) arent taking them long-term, Lee said in an interview.
What to Do if Tirzepatide Has Been Left Unrefrigerated If tirzepatide is accidentally left at room temperature, the safety depends on duration and ambient temperature
That physician-led, evaluation-first model is what separates a credible peptide therapy clinic from a general wellness spa
Formulary Tier Placement Where tirzepatide lands on your plan's formulary affects your copay directly
RELITEST-E 250MG (TESTOSTRRONE ENANTHATE) offers established medicinal advantages in supporting testosterone balance, muscle mass maintenance, bone strength support, and overall physical well-being